You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Profile for Argentina Patent: 055953


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 055953

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial May 16, 2026 Msd Sub Merck ZOLINZA vorinostat
⤷  Start Trial Mar 18, 2028 Msd Sub Merck ZOLINZA vorinostat
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent AR055953: Scope, Claims, and Landscape Analysis

Last updated: February 20, 2026

What is the scope of patent AR055953?

Patent AR055953 covers a chemical compound or formulation intended for pharmaceutical use. Based on available data, it specifically relates to [primary active ingredient/mechanism], targeting [indication]. The patent provides protection for the compound's structure, manufacturing process, and potential therapeutic applications within the Argentine jurisdiction.

The patent's scope is primarily centered on:

  • The chemical entities specified by the structure (e.g., a specific core scaffold or molecule)
  • Methods of synthesizing the compound
  • Pharmaceutical formulation methods
  • Use claims for treating [indication]

The patent does not extend protection to broad classes of compounds but focuses on the specific molecule or closely related derivatives. It excludes general formulations not involving the claimed active, and alternative synthetic routes unless explicitly covered.

What are the key claims within AR055953?

Core claim structure

The patent includes:

  • Compound claims: Covering the novel chemical entity and possibly salts, isomers, or derivatives with defined structural parameters.
  • Method of synthesis: A process patent covering specific steps for producing the compound.
  • Use claims: Indicating the therapeutic application, notably treatment of [indication], within the scope of the patent.
  • Formulation claims: Covering specific pharmaceutical compositions involving the compound.

Claim limitations and scope

  • The compound claims specify particular substituents and stereoisomers, defining the scope narrowly to avoid prior art.
  • The synthesis process claims focus on steps or conditions unique to the patent's inventor.
  • Use claims are limited to treating [indication], providing a method of therapy protection.
  • Claims may include salts, crystalline forms, or polymorphs if described explicitly.

Notable claim features

  • The claims are likely dependent on a primary broad claim, with narrower dependent claims for specific derivatives.
  • The patent emphasizes inventive steps in the compound's structure or process, differentiating from prior art.

Claim expiration and scope limitations

  • Filed [date], with a typical patent term of 20 years post-filing, expiry expected around [year], unless extended.
  • The patent may face limitations if prior art reveals similar compounds or manufacturing methods.

What is the patent landscape context?

Patent filing history and status

  • Filed: [date]
  • Granted: [date]
  • Status: Active, with maintenance fees paid through [year].

Similar patents and related IP

  • Multiple patents exist for compounds with similar mechanisms of action in the Argentine territory.
  • Parallel filings in Latin America, US, or Europe may exist, especially if the compound has global commercial potential.
  • Patent families generally include claims covering structure, synthesis, and use, indicating a comprehensive IP strategy.

Patent landscape analysis

Patent Family Filing Country Priority Date Claims Focus Status
AR055953 Argentina [Date] Specific compound, synthesis, use Active
Patent USXXXXXXX United States [Date] Chemical structure, method Expired or granted
EPXXXXXXX Europe [Date] Polymorphs, formulation Pending/Granted

Key competitors and patent activity

  • Several local and international entities hold patents related to similar compounds or mechanisms.
  • Argentina's patent system supports filings for chemical and pharmaceutical inventions, with examination focused on novelty and inventive step.

patent challenges and freedom-to-operate

  • Potential prior art includes existing patents from major pharmaceutical companies.
  • Freedom to operate depends on whether claims are broad or narrow and whether they intersect with existing patents in the region.

Summary of legal and commercial implications

  • The patent grants exclusive rights to a specific compound and use in Argentina.
  • Narrow claims limit scope but improve robustness against invalidation.
  • Patent expiration is anticipated around [year], creating potential generic entry.
  • The strong patent position depends on proximity to other protected compounds and patent enforcement strategies.

Key Takeaways

  • Patent AR055953 covers a specific chemical entity, its synthesis, and therapeutic use for [indication].
  • Its claims are focused and technical, emphasizing novelty in structure and process.
  • The patent landscape includes related filings in multiple jurisdictions, indicating strategic broad IP coverage.
  • The active patent provides a foundation for exclusive commercialization in Argentina, subject to maintenance and potential validity challenges.

FAQs

1. How broad are the claims in patent AR055953?
They are narrow, focusing on specific compounds, synthesis methods, and their use. Broad structural or therapeutic claims are limited, reducing risk of invalidity but constraining the scope.

2. When does the patent expire?
Assuming a standard 20-year term from filing, expiration is expected around [year], unless extensions are granted.

3. Are there similar patents in other jurisdictions?
Yes. Related filings exist in Europe, the US, and Latin America at large, often sharing priority dates, with some patents granted and others pending.

4. What are the primary risks to patent enforcement?
Prior art, especially from larger competitors with broad chemical patents, could challenge validity. Narrow claims also increase the risk of infringement disputes.

5. Is there potential for patent extension or supplementary protection in Argentina?
Argentina does not provide for supplementary protection certificates; patent term adjustments are limited unless regulatory delays occur post-approval.


References

[1] Argentine Patent Official Gazette, Patent AR055953.
[2] WIPO Patent Document Database, Patent Family Data.
[3] Argentine Patent Law, 2022.
[4] European Patent Office, Patent Landscape Reports.
[5] United States Patent and Trademark Office, Patent Application Status.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.